iRadimed
IRMD
$44.70
Share price
1.94%
Change (1 day)
3.59%
Change (1 year)
Categories
Operating Margin for iRadimed (IRMD)
Operating Margin as of May 2024 (TTM): 30.93%
According to iRadimed's latest financial reports and stock price the company's current Operating Margin is 30.93%. At the end of 2021 the company had an Operating Margin of 23.52%.
Operating Margin history for iRadimed from 2013 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 23.52% | -1309.49% |
| 2020 | -1.94% | -108.28% |
| 2019 | 23.48% | 15.32% |
| 2018 | 20.36% | 236.54% |
| 2017 | 6.05% | -82.05% |
| 2016 | 33.70% | -8.48% |
| 2015 | 36.83% | 91.04% |
| 2014 | 19.28% | -21.47% |
| 2013 | 24.55% | 31.73% |
| 2012 | 18.63% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | 31.50% | 1.84% | 🇺🇸 USA |
 NuVasive NUVA | 4.35% | -85.94% | 🇺🇸 USA |
 DexCom DXCM | 13.43% | -56.58% | 🇺🇸 USA |
 AtriCure ATRC | -13.98% | -145.20% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.